Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M674Revenue $M47.1Net Margin (%)0Z-Score9.7
Enterprise Value $M502EPS $-2.6Operating Margin %0F-Score2
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yN
Price/Book3.810-y EBITDA Growth Rate %0Quick Ratio7.4Cash flow > EarningsY
Price/Sales05-y EBITDA Growth Rate %16.6Current Ratio7.4Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-64.3Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-73.4Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M48.5ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with INFI

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
INFIJohn Burbank 2014-06-30 Sold Out -0.01%$8.6 - $12.67
($10.38)
$ 13.5430%Sold Out0
INFIJohn Burbank 2014-03-31 Buy 0.01%$11.37 - $16.52
($13.45)
$ 13.541%New holding, 16556 sh.16,556
INFIGeorge Soros 2013-06-30 Sold Out -0.02%$16.192 - $50.09
($30.95)
$ 13.54-56%Sold Out0
INFIGeorge Soros 2013-03-31 Reduce-0.01%$32.93 - $49.37
($39.51)
$ 13.54-66%Reduce -46.67%40,000
INFIGeorge Soros 2012-12-31 Buy 0.03%$17.74 - $35.04
($25.26)
$ 13.54-46%New holding, 75000 sh.75,000
INFIJean-Marie Eveillard 2012-06-30 Sold Out -0.01%$11.71 - $13.76
($12.78)
$ 13.546%Sold Out0
INFIJean-Marie Eveillard 2012-03-31 Reduce-0.01%$5.9781 - $12.16
($7.96)
$ 13.5470%Reduce -54.94%180,000
INFIJean-Marie Eveillard 2011-09-30 Reduce-0.01%$6.17 - $10.36
($7.87)
$ 13.5472%Reduce -25.85%464,241
INFIWilbur Ross 2011-06-30 Sold Out $5.61 - $8.19
($6.53)
$ 13.54107%Sold Out0
INFIJean-Marie Eveillard 2010-12-31 Add0.01%$5.12 - $6.86
($6.13)
$ 13.54121%Add 60.34%585,437
INFIWilbur Ross 2010-12-31 Reduce-0.02%$5.12 - $6.86
($6.13)
$ 13.54121%Reduce -63.91%7,415
INFIJean-Marie Eveillard 2010-09-30 Add$4.62 - $6.3
($5.51)
$ 13.54146%Add 29.72%365,123
INFIWilbur Ross 2010-09-30 Reduce-0.01%$4.62 - $6.3
($5.51)
$ 13.54146%Reduce -25.39%20,545
INFIJean-Marie Eveillard 2010-06-30 Add0.01%$5.88 - $7.94
($6.59)
$ 13.54106%Add 566.95%281,460
INFIJean-Marie Eveillard 2009-12-31 Add$5.5 - $6.57
($5.92)
$ 13.54129%Add 451.43%42,201
INFIJean-Marie Eveillard 2009-09-30 Buy $5.42 - $8.8
($6.97)
$ 13.5494%New holding, 7653 sh.7,653
INFIWilbur Ross 2009-03-31 Buy 0.12%$7.1 - $8.28
($7.9)
$ 13.5471%New holding, 28437 sh.28,437
INFIJean-Marie Eveillard 2008-12-31 Buy $4.73 - $8.05
($6.3)
$ 13.54115%New holding, 28100 sh.28,100
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

INFI is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
INFI John Burbank 2014-06-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


INFI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Palombella Vito J.Chief Scientific Officer 2014-09-03Sell9,472$15.39-10.98view
Palombella Vito J.Chief Scientific Officer 2014-07-01Sell879$12.876.45view
Palombella Vito J.Chief Scientific Officer 2014-02-25Sell4,736$15-8.67view
Palombella Vito J.Chief Scientific Officer 2014-01-02Sell753$13.521.33view
EVNIN ANTHONY BDirector 2013-12-02Sell17,756$14.56-5.91view
EVNIN ANTHONY BDirector 2013-11-27Sell163,864$14.82-7.56view
Palombella Vito J.Chief Scientific Officer 2013-09-27Sell4,736$17.28-20.72view
Perkins Adelene QPres & CEO 2013-09-13Sell45,000$20.72-33.88view
Palombella Vito J.Chief Scientific Officer 2013-06-20Sell23,150$18.53-26.07view
Rosebay Medical Co L.P.10% Owner 2013-04-16Sell5,708,283$38.4-64.32view

Press Releases about INFI :

    Quarterly/Annual Reports about INFI:

    News about INFI:

    Articles On GuruFocus.com
    comment on INFI Mar 02 2013 
    INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q/A) Mar 15 2011 
    INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q/A) Mar 15 2011 
    INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q/A) Mar 15 2011 
    INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q) Aug 04 2010 
    INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q) May 06 2010 
    INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q) Aug 06 2009 
    Infinity Pharmaceuticals Inc. Reports Operating Results (10-Q) May 06 2009 

    More From Other Websites
    Nasdaq stocks posting largest percentage increases Sep 30 2014
    INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement Sep 26 2014
    Stock Trading Ideas for 9/10/12 Sep 10 2014
    Infinity Pharmaceuticals (INFI) Soars: Stock Rises 7.1% Sep 09 2014
    Pharmacyclics Price Target Cut On Higher Spending Sep 08 2014
    Will AbbVie's $805 Million Agreement for Duvelisib Pay Off? Sep 04 2014
    Infinity, AbbVie team on drug Sep 03 2014
    Infinity Pharma (INFI) Shares Skyrocket on Cancer Drug Partnership Sep 03 2014
    [video] Stocks Close Mixed on Apple, Tesla Chooses Nevada for 'Gigafactory' Sep 03 2014
    Is Infinity Fully Valued Now, or Is More Upside Left? Sep 03 2014
    [video] Infinity Pharma teams up with AbbVie for cancer drug Sep 03 2014
    Infinity Pharma Joins AbbVie On Blood Cancer Drug Sep 03 2014
    Infinity Up Big on AbbVie Deal, Small Pharma in Focus Sep 03 2014
    Why Infinity Pharmaceuticals (INFI) Stock Is Soaring Today Sep 03 2014
    BUZZ-U.S. Stocks on the Move-Delta, Helen of Troy, Infinity Sep 03 2014
    BUZZ-U.S. Stocks on the Move-Capital Product, Infinity, Tetraphase Sep 03 2014
    Stock Futures Up And Climbing; Baidu Heads China Stock Rally Sep 03 2014
    Infinity Pharmaceuticals Inc and AbbVie to Discuss Strategic Collaboration In Oncology Call... Sep 03 2014
    BUZZ-U.S. Stocks on the Move-Capital Product, Infinity, Tetraphase Sep 03 2014
    INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other... Sep 03 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK